Arkolith/Insider Trading/BLSM/Form 4

Chen Bihua

Director, 10% OwnerBlossomHill Therapeutics, Inc. (BLSM) · full profile →Form 4 · filed Aug 10, 2026
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 10, 2026Conversion(C)1.6M——1.6M
Aug 10, 2026Conversion(C)1.7M——3.3M
Aug 10, 2026Buy(P)313K$16.00$5.0M3.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 10, 2026Conversion(C)1.6M——0
Aug 10, 2026Conversion(C)1.7M——0
Aug 6, 2026Grant(A)24K—$024K

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000852) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for BlossomHill Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp